Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761032 · ClinicalTrials.gov registry record
Gauging Of Light Dependent Experiences Through Neuroimaging (GOLDEN)
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 22
- Enrollment target
NCT01761032: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01761032 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01761032 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
In the proposed study, the investigators will assess the brain's dopamine response to UVR light in individuals who use tanning beds both frequently and infrequently.
Primary Outcome
Determine if UVR induces striatal dopaminergic efflux is altered in compulsive tanners.
Interventions
- DEVICE Tanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-06 |
What the finished NCT01761032 record still lists
NCT01761032 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tanning is the first listed.
NCT01761032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01761032 about?
NCT01761032 is a clinical study titled "Gauging Of Light Dependent Experiences Through Neuroimaging (GOLDEN)". In the proposed study, the investigators will assess the brain's dopamine response to UVR light in individuals who use tanning beds both frequently and infrequently.
What is the current status of trial NCT01761032?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2013-01. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01761032?
The interventions under investigation include: Tanning (DEVICE).
Who is sponsoring clinical trial NCT01761032?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia